MedPath

Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population

Not Applicable
Terminated
Conditions
Indication for Modification of Patient Physical Status
Interventions
Device: Vela XL thulium laser, laser fiber and accessories.
Registration Number
NCT02636738
Lead Sponsor
Boston Scientific Corporation
Brief Summary

Prospective, multicenter, single-arm, non-controlled, 60 subjects enrolled and 14 days follow up for evaluate the safety and utility of VelaTM XL thulium laser.

Detailed Description

This study aimed to evaluate the safety and utility of VelaTM XL thulium laser in cutting and hemostasis for gastrointestinal epithelial neoplasia in Chinese population.

Vela China study will enroll at least 60 patients. Follow up points are 72 ±3 hours post procedure, 7±2 days post procedure, 14 days(±2 days) post procedure.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Willing and able to provide written informed consent to participate in the study and comply with the study procedures.
  • Diagnosed as gastrointestinal epithelial neoplasia and admitted to hospital for gastrointestinal ESD procedure.
  • EUS and/or CT are performed to confirm the absence of regional lymph node or distant metastasis.
Exclusion Criteria
  • Endoscopic techniques or treatment are contraindicated.
  • Requirement for anticoagulation that cannot be safely stopped at least 7 days prior to the procedure.
  • Based on doctor's evaluation, the patient's medical condition doesn't fit for this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
experimentVela XL thulium laser, laser fiber and accessories.Vela XL thulium laser, laser fiber and accessories
Primary Outcome Measures
NameTimeMethod
Technique success1 hour

The procedure is mostly completed solely at one ESD procedure by VelaTM XL thulium laser, only if the direction of the laser could not be adjacent to the target, endoscopy knives will be assisted. The technique success rate will be calculated by the ratio of operation success subjects to total enrolled subjects.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Nanfang Hospital

🇨🇳

Guangzhou, Guangdong, China

Beijing Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath